Paratek Pharmaceuticals, Inc
- Biotech or pharma, therapeutic R&D
Paratek Pharmaceuticals is a commercial biopharmaceutical company calling on hospitals and the community including primary care providers and specialists. Conference focus is on identifying commercial Rx and late-stage assets (late Phase III onward) for US strategic acquisition, in-licensing, and commercial partnering and identifying potential out-licensing partners for NUZYRA which was identified as a high priority drug for Japan by the Japanese government. This is for Nontuberculous Mycobacteria (NTM) a rara disease with high unmet need that is Phase III-ready.
Address
King of PrussiaPennsylvania
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}